Agatha key facts
as of Oct 2026- Developer of a document management platform intended to organize the healthcare and life sciences industry's workflow.
- Agatha is valued at approximately $22.6M as of Oct 2026 (last reported valuation).
- It has raised $8.0M; the latest was PE Growth/Expansion in Apr 2025.
- Notable investors include Salesforce Ventures, Japan Finance Corporation, GMO Venture Partners, One Capital (Tokyo), ARCHIMED — 8 tracked in total.
- Status: Privately Held (backing).
Agatha's last reported valuation, Nov 2021. Nothing priced has surfaced since.
- ·Watch Agatha: the Monday email on marks, rounds and moves
Agatha funding rounds
No funding rounds for Agatha are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Agatha valuation
Agatha's last reported valuation was $22.6 million in Nov 2021. No priced round, secondary trade or fund mark has surfaced since.
Agatha investors
8 investors are on record for Agatha, including Salesforce Ventures, Japan Finance Corporation, GMO Venture Partners and One Capital (Tokyo).
About Agatha
Developer of a document management platform intended to organize the healthcare and life sciences industry's workflow. The company's platform provides standard modules and cloud services for clinical research and clinical trials to medical institutions and pharmaceutical companies, enabling clients to optimize the quality in managing clinical documentation and processes.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2015
- Employees
- 58
- Website
- agathalife.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.